About Y-Trap

About company

Y-Trap, Inc. is a biotechnology company focused on the development of revolutionary technologies for cancer immunotherapy. The company’s patented technology, licensed from Johns Hopkins University, is a novel platform of targeted multifunctional immunomodulatory antibody-ligand traps (“Y-traps”) for cancer immunotherapy. The ability of this novel class of next-generation multifunctional antibody-ligand traps to unleash potent antitumor immune responses offers a promising targeted immunotherapeutic strategy for many types of advanced and treatment-refractory cancers that evade current monoclonal antibodies and immune checkpoint inhibitors. Y-Trap, Inc. is located in the Science + Technology Park at Johns Hopkins,